Waverly Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.6M Buy
272,321
+4,561
+2% +$1.06M 0.5% 39
2025
Q4
$55.4M Buy
267,760
+95,480
+55% +$18.9M 0.45% 48
2025
Q3
$31.9M Buy
172,280
+13,308
+8% +$2.28M 0.32% 64
2025
Q2
$24.3M Buy
158,972
+1,305
+0.8% +$201K 0.27% 79
2025
Q1
$26.1M Buy
157,667
+21,229
+16% +$3.32M 0.32% 74
2024
Q4
$19.7M Buy
136,438
+24,969
+22% +$3.87M 0.31% 65
2024
Q3
$18.1M Sell
111,469
-12,783
-10% -$2.04M 0.33% 57
2024
Q2
$18.2M Buy
124,252
+23,621
+23% +$3.51M 0.36% 51
2024
Q1
$15.9M Buy
100,631
+23,297
+30% +$3.71M 0.37% 53
2023
Q4
$12.1M Buy
77,334
+24,318
+46% +$3.73M 0.45% 38
2023
Q3
$8.26M Buy
53,016
+32,084
+153% +$5.29M 0.36% 53
2023
Q2
$3.46M Buy
20,932
+4,453
+27% +$719K 0.15% 97
2023
Q1
$2.55M Sell
16,479
-18,290
-53% -$2.95M 0.13% 89
2022
Q4
$6.14M Buy
34,769
+2,108
+6% +$364K 0.34% 51
2022
Q3
$5.33M Buy
32,661
+24,145
+284% +$4.09M 0.38% 40
2022
Q2
$1.51M Sell
8,516
-52
-0.6% -$9.27K 0.14% 65
2022
Q1
$1.52M Hold
8,568
0.13% 58
2021
Q4
$1.44M Sell
8,568
-376
-4% -$61.6K 0.12% 59
2021
Q3
$1.46M Buy
8,944
+113
+1% +$19.3K 0.12% 62
2021
Q2
$1.56M Buy
8,831
+710
+9% +$118K 0.14% 55
2021
Q1
$1.39M Buy
8,121
+1,743
+27% +$282K 0.14% 60
2020
Q4
$1.06M Sell
6,378
-535
-8% -$79K 0.11% 64
2020
Q3
$948K Sell
6,913
-544
-7% -$80.5K 0.13% 62
2020
Q2
$1.1M Sell
7,457
-92
-1% -$13.4K 0.14% 58
2020
Q1
$990K Buy
7,549
+470
+7% +$66.7K 0.17% 53
2019
Q4
$1.09M Sell
7,079
-187
-3% -$25.4K 0.14% 59
2019
Q3
$940K Buy
7,266
+1,070
+17% +$141K 0.13% 60
2019
Q2
$863K Buy
6,196
+133
+2% +$18.4K 0.13% 60
2019
Q1
$848K Buy
6,063
+206
+4% +$27.6K 0.13% 58
2018
Q4
$756K Sell
5,857
-9,536
-62% -$1.33M 0.13% 57
2018
Q3
$2.13M Buy
15,393
+341
+2% +$45.3K 0.31% 34
2018
Q2
$1.83M Buy
15,052
+488
+3% +$60.9K 0.28% 43
2018
Q1
$1.87M Sell
14,564
-3,746
-20% -$506K 0.3% 39
2017
Q4
$2.56M Buy
18,310
+3,374
+23% +$470K 0.36% 34
2017
Q3
$1.94M Buy
14,936
+31
+0.2% +$4.11K 0.42% 37
2017
Q2
$1.97M Buy
14,905
+1,259
+9% +$161K 0.5% 32
2017
Q1
$1.7M Buy
13,646
+7,491
+122% +$895K 0.45% 33
2016
Q4
$709K Buy
6,155
+668
+12% +$77.2K 0.26% 44
2016
Q3
$648K Buy
5,487
+874
+19% +$106K 0.27% 40
2016
Q2
$560K Sell
4,613
-136
-3% -$15.5K 0.25% 40
2016
Q1
$514K Sell
4,749
-176
-4% -$18.2K 0.31% 40
2015
Q4
$506K Buy
4,925
+1,107
+29% +$111K 0.22% 53
2015
Q3
$356K Buy
3,818
+484
+15% +$46.8K 0.25% 38
2015
Q2
$325K Buy
3,334
+1,254
+60% +$126K 0.2% 38
2015
Q1
$209K Buy
2,080
+35
+2% +$3.56K 0.11% 46
2014
Q4
$214K Sell
2,045
-4,152
-67% -$438K 0.11% 51
2014
Q3
$661K Buy
6,197
+309
+5% +$32K 0.36% 28
2014
Q2
$616K Sell
5,888
-63
-1% -$6.37K 0.26% 37
2014
Q1
$585K Sell
5,951
-3,216
-35% -$298K 0.26% 35
2013
Q4
$840K Buy
9,167
+4,634
+102% +$427K 0.3% 35
2013
Q3
$393K Buy
4,533
+252
+6% +$22.6K 0.2% 54
2013
Q2
$368K Buy
+4,281
New +$363K 0.21% 56

Other funds holding JNJ

Waverly Advisors's JNJ Position: Q1 2026 in Review

Waverly Advisors increased its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2026, buying an estimated $1.06M and bringing the position to 272,321 shares worth $66.6M. The position accounts for 0.5% of the portfolio, ranked #39.

Waverly Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Waverly Advisors held 272,321 shares of Johnson & Johnson worth $66.6M as of Q1 2026.
  • Waverly Advisors bought 4,561 Johnson & Johnson shares in Q1 2026, an estimated $1.06M.
  • Johnson & Johnson made up 0.5% of Waverly Advisors's portfolio in Q1 2026, its #39 holding.
  • Waverly Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.